Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SSKN
11626
DELISTED
Strata Skin Sciences
SSKN
| $60.1K | ﹤0.01% |
+21,852
| New | +$68.3K |
2024 Q3
0 quarters
|
|
|
FFAI
11627
Faraday Future Intelligent Electric
FFAI
$6.92M
| $60.1K | ﹤0.01% |
+140
| New | +$195K |
2023 Q1
6 quarters
|
|
11628
CALL
Vanguard Total Bond Market
BND
$158B
| $60.1K | ﹤0.01% |
800
-700
| -47% | -$51.8K |
2018 Q2
25 quarters
|
|
11629
CALL
Quantum-Si Incorporated
QSI
$278M
| $60.1K | ﹤0.01% |
68,100
+17,800
| +35% | +$17.3K |
2021 Q1
14 quarters
|
|
11630
CALL
BuzzFeed
BZFD
$108M
| $60K | ﹤0.01% |
22,525
+1,150
| +5% | +$3.06K |
2023 Q4
3 quarters
|
|
|
OLO
11631
PUT
DELISTED
Olo Inc
OLO
| $60K | ﹤0.01% |
+12,100
| New | +$59.8K |
2024 Q3
0 quarters
|
|
|
TMQ
11632
Trilogy Metals
TMQ
$519M
| $59.9K | ﹤0.01% |
123,833
+78,705
| +174% | +$43.6K |
2022 Q4
7 quarters
|
|
11633
CALL
Global X MLP & Energy Infrastructure ETF
MLPX
$3.49B
| $59.9K | ﹤0.01% |
1,100
| – | – |
2021 Q3
12 quarters
|
|
11634
PUT
NewAmsterdam Pharma
NAMS
$2.65B
| $59.8K | ﹤0.01% |
3,600
+400
| +13% | +$6.92K |
2024 Q2
1 quarter
|
|
|
SMCX
11635
CALL
Defiance Daily Target 2X Long SMCI ETF
SMCX
$224M
| $59.8K | ﹤0.01% |
+193
| New | +$77.8K |
2024 Q3
0 quarters
|
|
11636
PUT
Stem
STEM
$42.9M
| $59.8K | ﹤0.01% |
8,580
+2,005
| +30% | +$31.6K |
2021 Q1
14 quarters
|
|
11637
CALL
TriCo Bancshares
TCBK
$1.64B
| $59.7K | ﹤0.01% |
1,400
+800
| +133% | +$34.5K |
2022 Q4
7 quarters
|
|
11638
Vanguard Russell 2000 ETF
VTWO
$16.3B
| $59.7K | ﹤0.01% |
668
-232,765
| -100% | -$20.1M |
2022 Q2
9 quarters
|
|
11639
CALL
NRX Pharmaceuticals
NRXP
$126M
| $59.7K | ﹤0.01% |
35,300
+12,890
| +58% | +$26K |
2021 Q3
12 quarters
|
|
11640
PUT
Acacia Research
ACTG
$423M
| $59.6K | ﹤0.01% |
12,800
+1,400
| +12% | +$6.92K |
2022 Q4
7 quarters
|
|
|
SELF
11641
Global Self Storage
SELF
$56M
| $59.6K | ﹤0.01% |
11,442
-3,888
| -25% | -$19.7K |
2022 Q4
7 quarters
|
|
11642
Solitario Resources
XPL
$52.6M
| $59.6K | ﹤0.01% |
85,113
-1,721
| -2% | -$1.39K |
2023 Q1
6 quarters
|
|
|
HAYN
11643
PUT
DELISTED
Haynes International, Inc.
HAYN
| $59.5K | ﹤0.01% |
1,000
-1,000
| -50% | -$59.5K |
2022 Q4
7 quarters
|
|
|
CREG
11644
DELISTED
Smart Powerr
CREG
| $59.5K | ﹤0.01% |
676
+220
| +48% | +$20.1K |
2024 Q2
1 quarter
|
|
11645
PUT
Skye Bioscience
SKYE
$7.17M
| $59.4K | ﹤0.01% |
1,900
+1,762
| +1,277% | +$79.1K |
2024 Q2
1 quarter
|
|
11646
CALL
TXO Partners LP
TXO
$771M
| $59.3K | ﹤0.01% |
+3,000
| New | +$59.4K |
2024 Q3
0 quarters
|
|
11647
ProShares UltraShort Financials
SKF
$12.8M
| $59.3K | ﹤0.01% |
+1,456
| New | +$64.7K |
2024 Q3
0 quarters
|
|
11648
CALL
US Physical Therapy
USPH
$1.24B
| $59.2K | ﹤0.01% |
700
+100
| +17% | +$8.87K |
2022 Q2
9 quarters
|
|
11649
PUT
Perimeter Solutions
PRM
$4.64B
| $59.2K | ﹤0.01% |
4,400
+800
| +22% | +$8.29K |
2022 Q4
7 quarters
|
|
11650
SELLAS Life Sciences
SLS
$2.28B
| $59.1K | ﹤0.01% |
+47,319
| New | +$57.8K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.